Lyka Labs Share Price

Lyka Labs Limited is an India-based pharmaceutical company engaged in the development, manufacture and marketing of quality finished dosages. The Company manufactures pharmaceutical products such as Dry Powder, Liquid, Lyophilized Injections and External Preparations for several International Markets and the Domestic Market. The Company’s R&D is engaged in the development of new formulations and has developed several products in the categories, such as Injectables: Lyophilized Injection, Liquid Injections & Dry Powder Injections, and Topical Preparation: Ointment /Creams and Lotions. It offers formulations, such as emollient, anti-aging, cleansing lotion, hair care products, anti-dandruff shampoo, sunscreen, anti-acne, antioxidant tablets, antioxidants combination, proton pump inhibitor, antifungal, anti-malarial, antibacterial, corticosteroid hormones and cephalosporins. The Company's subsidiaries include Lyka BDR International Limited and Lyka Exports Limited.As of 25 May 2026, Lyka Labs share price is ₹61.72. The stock opened at ₹62.27, compared to its previous close of ₹61.41. During today's trading session, Lyka Labs share price moved in the range of ₹61.20 to ₹64.00, with an average price of ₹62.60 for the day. Looking at its last 52-week, the stock has touched a low of ₹61.20 and a high of ₹64.00. On the performance front, Lyka Labs share price has declined by 26.07% over the last six months and is down 47.22% on a year-on-year basis.

The market capitalization of Lyka Labs is ₹220 Crs, with a P/E ratio of -617.5 and a dividend yield of 0.00%.